Michael is a results-driven biopharmaceutical leader with over 20 years of experience managing drug substance and product manufacturing from pre-clinical to late-stage phases. He holds a B. S. from Elon University and an M. B. A. from Strayer University, specializing in technology transfer, process scale-up, and leading scientific teams.
While at REGENXBIO, he led a team to develop and patent an improved cell culture process.
Read the full overview →
Experience
24 Years
Current Role
Senior Director, CMC
Job Level
Senior
Location
Washington DC-Baltimore Area, United States
Personality Overview
How Michael shows up
Value Seeker
Not Easily Convinced
Systematic
They prefer to fully evaluate every situation. It is quite likely of them to ask for pricing or other concessions. They generally do not appreciate an overfriendly approach and prefer to stay to-the-point.
Priorities
Topics Michael cares about
Technology Transfer
A core expertise highlighted across his career, focused on bringing gene therapies and monoclonal antibodies to market by managing internal and external manufacturing transfers.
CMC Leadership
He has a proven record of leading and building teams of bioprocess engineers and scientists at companies like Salubris Biotherapeutics, Sensei Bio, and REGENXBIO.
+5 more topicsLogin to view topics
Career
Work history
6-2023
Senior Director, CMC
Salubris Biotherapeutics
5-2021 - 3-2023
Director, Antibody CMC, Technical Operations
Sensei Bio
1-2018 - 5-2021
Associate Director, Technology Transfer
REGENXBIO Inc.
2-2017 - 12-2017
Senior Scientist
REGENXBIO Inc.
10-2015 - 11-2016
Business and Technical Project Manager
Novavax
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
More profiles
Discover additional public profiles from our index.